Alnylam Pharmaceuticals (NASDAQ:ALNY) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per…
Alnylam Pharmaceuticals (NASDAQ:ALNY) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.25, beating the consensus estimate of $1.20 by $0.05 per share. Revenue came in at $1.1B, missing the estimate of $1.2B.
Alnylam Pharmaceuticals's stock moved following the earnings release. The stock currently trades at $314.40 with a market capitalization of $54.5B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · ALNY
$237.10
Up: +$4.19 · +1.77%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
sec_filing ·
